Jang Jeong-Hoon, Kim Do-Hee, Surh Young-Joon
Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, South Korea.
Department of Chemistry, College of Convergence and Integrated Science, Kyonggi University, Suwon, Gyeonggi-do, South Korea.
NPJ Precis Oncol. 2021 Mar 8;5(1):18. doi: 10.1038/s41698-021-00154-7.
The inflammatory tumor microenvironment has been known to be closely connected to all stages of cancer development, including initiation, promotion, and progression. Systemic inflammation in the tumor microenvironment is increasingly being recognized as an important prognostic marker in cancer patients. Inflammasomes are master regulators in the first line of host defense for the initiation of innate immune responses. Inflammasomes sense pathogen-associated molecular patterns and damage-associated molecular patterns, following recruitment of immune cells into infection sites. Therefore, dysregulated expression/activation of inflammasomes is implicated in pathogenesis of diverse inflammatory disorders. Recent studies have demonstrated that inflammasomes play a vital role in regulating the development and progression of cancer. This review focuses on fate-determining roles of the inflammasomes and the principal downstream effector cytokine, IL-1β, in the tumor microenvironment.
炎症性肿瘤微环境已被认为与癌症发展的各个阶段密切相关,包括起始、促进和进展。肿瘤微环境中的全身炎症越来越被认为是癌症患者的一个重要预后标志物。炎性小体是宿主防御启动先天性免疫反应的第一道防线中的主要调节因子。炎性小体感知病原体相关分子模式和损伤相关分子模式,随后将免疫细胞募集到感染部位。因此,炎性小体的表达/激活失调与多种炎症性疾病的发病机制有关。最近的研究表明,炎性小体在调节癌症的发展和进展中起着至关重要的作用。本综述重点关注炎性小体和主要下游效应细胞因子IL-1β在肿瘤微环境中的命运决定作用。